The problem of intratumoral heterogeneity, which is observed in 40% of BC casesand can be represented in the coexistence of many subpopulations of cells withdifferent HER2/neu expression levels in the same tumor, remains unsolved [34, 35]. Here, ERBB2 is linked to breast cancer.